Login to Your Account

Avillion Gets Initial Funding, Helps Pharma Pick Up Pace

By Nuala Moran
Staff Writer

Tuesday, January 29, 2013
Pharma's productivity woes have spawned a new UK company, Avillion LLP, which is offering to plug between $50 million and $100 million into the co-development of Phase III assets.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription